Claims for Patent: 10,888,534

Summary for Patent: 10,888,534

Title:	Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags
Abstract:	A sterile, sulfite-free aqueous norepinephrine solution comprising up to about 0.2 mg/ml of norepinephrine concentration (as free base), a tonicity adjusting agent, at a pH where the norepinephrine is soluble which is packaged in a flexible plastic container, characterized by being storage stable for from about 12 months to about 24 months at room temperature of about 25.degree. C.
Inventor(s):	Dusci; Sergio (Tresivio, IT), Dusci; Sayan (Tresivio, IT)
Assignee:	InfoRLife SA (Campascio, CH)
Application Number:	16/395,541
Patent Claims:	1. A sterile, antioxidant-free aqueous norepinephrine solution packaged in a flexible plastic container in a sealed over-wrap pouch containing an oxygen absorber consisting essentially of between about 0.010 and 0.2 mg/ml of norepinephrine concentration as free base, a tonicity adjusting agent to provide an osmolality of from 260 and 320 mosm/kg, and sufficient acid and optionally a base to provide a pH of from about 3.6 to 3.8, with the remainder water, and wherein dissolved oxygen in the solution has not been removed before filling the flexible plastic container with the solution, and wherein, after storage for from 12 months to about 24 months at room temperature of about 25.degree. C., the solution remains clear and colorless and/or the solution contains 90% or more of an initial amount of norepinephrine. 2. The sterile, antioxidant-free aqueous norepinephrine solution of claim 1 wherein the norepinephrine concentration is between 0.015 and 0.07 mg/ml. 3. The sterile, antioxidant-free aqueous norepinephrine solution of claim 2 wherein the norepinephrine concentration is selected from about 0.016, about 0.032 and about 0.064 mg/nil of norepinephrine. 4. The sterile, antioxidant-free aqueous norepinephrine solution of claim 3 wherein the norepinephrine concentration is about 0.016 mg/ml. 5. The sterile, antioxidant-free aqueous norepinephrine solution of claim 3 wherein the norepinephrine concentration is about 0.032 mg/ml. 6. The sterile, antioxidant-free aqueous norepinephrine solution of claim 3 wherein the norepinephrine concentration is about 0.064 mg/ml. 7. The sterile, antioxidant-free aqueous norepinephrine solution of claim 1 wherein the tonicity adjusting agent is sodium chloride. 8. The sterile, antioxidant-free aqueous norepinephrine solution of claim 7 wherein the amount of sodium chloride is between about 8 and 10 mg/ml. 9. The sterile, antioxidant-free aqueous norepinephrine solution of claim 8 wherein the amount of sodium chloride is between about 8.5 and 9.5 mg/ml. 10. The sterile, antioxidant-free aqueous norepinephrine solution of claim 9 wherein the amount of sodium chloride is about 9 mg/ml. 11. The sterile, antioxidant-free aqueous norepinephrine solution of claim 1 wherein the solution was aseptically sterilized. 12. The sterile, antioxidant-free aqueous norepinephrine solution of claim 1 wherein the flexible plastic container is packaged in a sealed over-wrap pouch containing an oxygen absorber and an oxygen indicator. 13. The sterile, antioxidant-free aqueous norepinephrine solution of claim 1 wherein the pH is greater than 3.6 and less than or equal to 3.8. 14. The sterile, antioxidant-free aqueous norepinephrine solution of claim 1 wherein the pH is 3.7 to 3.8. 15. The sterile, antioxidant-free aqueous norepinephrine solution of claim 1 wherein the flexible plastic container is filled with the solution aseptically.